APC Policy
Article Processing Charges (APC) Policy
Pharmacological Horizons is committed to promoting the free and equitable dissemination of scientific knowledge. The journal believes that high-quality research should be accessible to authors and readers without unnecessary financial barriers.
No Submission Fee
Authors are not required to pay any fee for manuscript submission. All submitted manuscripts are processed through the editorial screening and peer-review stages without any submission charges.
No Article Processing Charges (APC)
Pharmacological Horizons currently does not charge any Article Processing Charges (APCs) for accepted manuscripts. Authors are not required to pay publication fees, processing fees, handling fees, or editorial charges for the publication of their research.
No Hidden Costs
The journal maintains a transparent publication model. There are no hidden charges associated with manuscript submission, editorial assessment, peer review, production, online publication, or article hosting.
Open Access Publishing
All articles published in Pharmacological Horizons are made freely available online immediately upon publication. Readers may access, read, download, and share published content without subscription or access fees.
Funding and Sustainability
The journal is committed to supporting researchers, academicians, and healthcare professionals by providing a platform for the dissemination of scientific knowledge without imposing financial burdens on authors.
Future Policy Updates
Any future changes to publication fees, Article Processing Charges, or journal funding policies will be clearly announced on the journal website. Such changes will be implemented transparently and in accordance with accepted scholarly publishing practices.
Current APC Status
• No Submission Fee
• No Article Processing Charges (APC)
• No Publication Fee
• No Hidden Charges
Pharmacological Horizons remains committed to maintaining accessible, ethical, and high-quality scholarly publishing for the global research community.